Ma Y, Han G Q, Wang Y Y
National Laboratory of Natural and Biomimetic Drugs, Beijing Medical University.
Yao Xue Xue Bao. 1993;28(5):370-3.
In a continuing search for PAF antagonists, five benzofuran neolignans have been isolated from the aerial part of Piper kadsura (Choisy) Ohwi, a Chinese traditional drug used for the treatment of inflammation and rheumatic conditions. The structure determination was based upon spectroscopic analysis. Two of the neolignans were found to have new structures and were named as (-)-denudatin B (the enantiomer of denudatin B, II) and kadsurenin M (7S,8S-3,4,3'-trimethoxy-7'-oxo-nor-8',9'-7.O. 4',8,5'-neolignan, V). The known compounds kadsurenon (I), (-)-acuminatin(III) and (+)-licarin A(IV) were also obtained from the same source. (-)-Denudatin B (II) showed potent PAF antagonistic activity in 3H-PAF receptor binding assay.
为了持续寻找血小板活化因子(PAF)拮抗剂,从海风藤(一种用于治疗炎症和风湿病症的传统中药)地上部分分离出了五种苯并呋喃新木脂素。结构鉴定基于光谱分析。其中两种新木脂素被发现具有新结构,分别命名为(-)-去甲络石苷B(络石苷B的对映体,II)和海风藤素M(7S,8S-3,4,3'-三甲氧基-7'-氧代-降-8',9'-7.O.4',8,5'-新木脂素,V)。还从同一来源获得了已知化合物海风藤酮(I)、(-)-尖叶新木脂素(III)和(+)-里卡灵A(IV)。(-)-去甲络石苷B(II)在3H-PAF受体结合试验中显示出较强的PAF拮抗活性。